|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 14-11-03 | Covance : Dow, S&P 500 close slightly lower; semis boost Nasdaq | RE |
| 14-11-03 | Covance : LabCorp to pay $6.1 billion for drug trial company Covance | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
| Corporate Officer/Principal | - | 2023-03-05 | |
Hong Gang Bi
PRN | Corporate Officer/Principal | 67 | 2011-05-30 |
Stephen Street
PRN | Corporate Officer/Principal | 65 | 2012-06-17 |
| Director | Title | Age | Since |
|---|---|---|---|
Glenn Eisenberg
BRD | Director/Board Member | 64 | 2015-02-18 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.29% | +3.13% | +11.66% | +36.37% | 49.06B | |
| +0.22% | +0.40% | +50.91% | +37.06% | 44.6B | |
| -1.58% | +4.66% | +359.34% | +614.38% | 43.24B | |
| +1.70% | +0.36% | +12.56% | +99.27% | 41.73B | |
| +0.51% | -1.71% | +5.18% | +46.87% | 29.93B | |
| -0.48% | -1.32% | +23.98% | +150.01% | 17.19B | |
| +0.08% | +9.03% | +8.41% | - | 15.35B | |
| -2.03% | -2.30% | +26.88% | +44.19% | 15.54B | |
| +1.97% | -3.17% | - | - | 15.11B | |
| Average | +0.01% | +1.85% | +62.36% | +146.88% | 30.19B | |
| Weighted average by Cap. | +0.02% | +2.26% | +78.00% | +160.86% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
